Alerts will be sent to your verified email
Verify Email
LYKALABS
|
Lyka Labs
|
Brooks Laboratories
|
Medico Remedies
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
145.3 % | -23.88 % | 11.79 % |
|
5yr average Equity Multiplier
|
-0.06 | 1.78 | 2.18 |
|
5yr Average Asset Turnover Ratio
|
0.64 | 0.6 | 1.48 |
|
5yr Avg Net Profit Margin
|
-21.64 % | -23.79 % | 3.76 % |
|
Price to Book
|
3.98 | 6.47 | 7.11 |
|
P/E
|
50.06 | 0.0 | 43.99 |
|
5yr Avg Cash Conversion Cycle
|
16.94 Days | -10.34 Days | 34.15 Days |
|
Inventory Days
|
26.54 Days | 93.5 Days | 52.67 Days |
|
Days Receivable
|
77.33 Days | 66.75 Days | 107.96 Days |
|
Days Payable
|
133.6 Days | 179.8 Days | 136.18 Days |
|
5yr Average Interest Coverage Ratio
|
0.6 | -11.84 | 9.64 |
|
5yr Avg ROCE
|
22.35 % | -15.03 % | 17.25 % |
|
5yr Avg Operating Profit Margin
|
20.24 % | -13.23 % | 5.84 % |
|
5 yr average Debt to Equity
|
-0.79 | 0.21 | 0.3 |
|
5yr CAGR Net Profit
|
-47.18 % | 0.22 % | 38.44 % |
|
5yr Average Return on Assets
|
-5.63 % | -14.62 % | 5.66 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
58.16 % | 52.62 % | 63.79 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
10.37 % | -13.79 % | -9.55 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.72 % | 9.9 % | 0.0 |
|
Lyka Labs
|
Brooks Laboratories
|
Medico Remedies
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|